Related Experiment Videos

Emerging therapies and future directions in chronic lymphocytic leukaemia--chemotherapy

¹Clinical Investigations Branch, National Cancer Institute, Bethesda, MD 20892-7436, USA.

Hematology and Cell Therapy

|October 19, 2000

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Current Status of U.S. Clinical Trials in Chronic Lymphocytic Leukemia.

Leukemia & lymphoma·2016

Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes.

Leukemia·2015

Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma.

Blood cancer journal·2014

How we manage follicular lymphoma.

Leukemia·2014

See all related articles